Nano-X Imaging is a disruptive biotech investment. The AI push in the health sector is a long-term tailwind. See why we rate ...

Stay updated with a weekly recap covering market movements, economic insights, top news, and geopolitical events shaping the ...

Gamification – Almost 60% of Gen Alpha have (as kids or teenagers) already discovered new brands, and are more likely to buy ...

Seagate's HDDs are crucial for AI models, offering cost-effective storage. Learn why STX stock is undervalued with strong ...

Cardlytics, Inc. offers an asymmetric investment opportunity for those who can handle stock price volatility and slow ...

Kiniksa Pharmaceuticals stock is attractive because it trades near 52-week lows, and its marketed drug gains traction. Click to find out why KNSA is a Hold.

Royalty Pharma's Q4 results show portfolio receipts of $742 million and operating cash flow of $678 million. Read why RPRX ...

What are the most attractive AI-adjacent stocks right now? We asked Seeking Alpha analysts Tech Stock Pros, Michael Wiggins ...

Gossamer Bio's Seralutinib shows promise for PAH and PH-ILD treatment. The main event comes with its topline results in Q4 ...

The feasibility study for GoGold's Los Ricos South shows a 15-year mine life with competitive costs and high initial ...

Zuorais set to be acquired by Silver Lake and GIC within the first quarter of 2025 for $10 per share. Read why I think now is ...

CEO Paul Stoffels highlighted 2024 as a pivotal year for Galapagos, emphasizing the FDA IND clearance for GLPG5101 and strong results from the ATALANTA study in non-Hodgkin lymphoma. He outlined the ...